We work in a highly risk-averse industry where even software upgrades are approached cautiously. SEND has driven huge change, but now AI and predictive toxicology are pushing boundaries even further. How do we balance risk...
What can our customers control that could help us make SEND faster and cheaper, without negatively impacting quality?
With the new Implementation Guide due to go on public review this coming August, we take a closer look at the scope of SEND 4.0.
The FDA has released a new version of the study data Technical Conformance Guide
A look at the main SEND discussion points at SOT 2023
When it comes to SEND “What is there to talk about?”, actually quite a lot.
